INNOHEP - 50222-342-08 - (tinzaparin sodium)

Alphabetical Index


Drug Information of INNOHEP

Product NDC: 50222-342
Proprietary Name: INNOHEP
Non Proprietary Name: tinzaparin sodium
Active Ingredient(s): 20000    [iU]/mL & nbsp;   tinzaparin sodium
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of INNOHEP

Product NDC: 50222-342
Labeler Name: LEO Pharma Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020484
Marketing Category: NDA
Start Marketing Date: 20100701

Package Information of INNOHEP

Package NDC: 50222-342-08
Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (50222-342-08) > 2 mL in 1 VIAL, MULTI-DOSE

NDC Information of INNOHEP

NDC Code 50222-342-08
Proprietary Name INNOHEP
Package Description 1 VIAL, MULTI-DOSE in 1 CARTON (50222-342-08) > 2 mL in 1 VIAL, MULTI-DOSE
Product NDC 50222-342
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name tinzaparin sodium
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20100701
Marketing Category Name NDA
Labeler Name LEO Pharma Inc.
Substance Name TINZAPARIN SODIUM
Strength Number 20000
Strength Unit [iU]/mL
Pharmaceutical Classes Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC]

Complete Information of INNOHEP


General Information